Anti-SARS-CoV-2 Spike Protein (BA.1) Human IgG ELISA Kit

PRINCIPLE OF THE ASSAY This assay employs the quantitative indirect enzyme immunoassay technique. Recombinant SARS-CoV-2 Spike Protein (BA.1) has been pre-coated onto a microplate. Standards or samples are pipetted into the wells and any Anti-SARS-CoV-2 Spike Protein (BA.1) Human IgG present is bound by the immobilized protein. After washing away any unbound substances, a HRP-labeled Goat Anti-Human IgG antibody is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Anti-SARS-CoV-2 Spike Protein (BA.1) Human IgG bound in the initial step. The color development is stopped and the intensity of the color is measured.

Used for the quantitative determination of Anti-SARS-CoV-2 Spike Protein (BA.1) Human IgG concentration in serum and plasma.

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

2-8 °C

For Research Use Only.